Article Sidebar

PDF
Date Published: 31/10/2023
Online Published: 31/10/2023
Abstract Views: 284
Views PDF: 168
DOI: https://doi.org/10.58490/ctump.2023i65.1795
Issue
No. 65 (2023)
Section
Article
How to Cite
Dang, N. T. H., Tran, C. C., Nguyen, T. H., & Le, V. M. (2023). ASSESSMENT OF TREATMENT RESULTS ON RECURRENT ISCHEMIC STROKE PATIENT AT CAN THO CENTRAL GENERAL HOSPITAL FROM 2022 TO 2023. Cantho Journal of Medicine and Pharmacy, 65, 80-86. https://doi.org/10.58490/ctump.2023i65.1795

ASSESSMENT OF TREATMENT RESULTS ON RECURRENT ISCHEMIC STROKE PATIENT AT CAN THO CENTRAL GENERAL HOSPITAL FROM 2022 TO 2023

Đặng Nguyễn Thanh Hiền1, Trần Chí Cường2, Thi Hien Nguyen3, Lê Văn Minh3,
1 Hoan My Cuu Long General Hospital
2 Can Tho Stroke International Services Hospital
3 Can Tho University of Medicine and Pharmacy

Main Article Content

Abstract

Background: Recurrent ischemic stroke after stroke leads to higher mortality, more significant disability, and increased treatment cost compared with the first and treatment needs to combine many factor. Objectives: To assess the treatment outcomes of recurrent ischemic stroke patients at Can Tho Central General Hospital from 2022 to 2023. Materials and method: A descriptive cross-sectional study. The study included 87 recurrent ischemic stroke patients who met the selection criteria. Results: Among the 87 recurrent ischemic stroke patients, 98.8% of patients received conservative management, while 1.1% were treated with fibrinolytic drugs. Among the recurrent ischemic stroke patients, 88.5% had favorable outcomes. The management results were found to be associated with lipid disorders, prior use of antiplatelet drugs, the number of noncontiguous infarct locations, aphasia, and National Institute of Health Stroke Scale at the time of hospital admission (p<0.05). Conclusion: It is necessary to evaluate the National Institute of Health Stroke Scale and related factors to improve the quality of treatment for recurrent ischemic stroke.

Article Details

Keywords

Recurrent ischemic stroke, management results, related factors

References

1. Saini V, Guada D, Yavagal DR(2021), Global epidemiology of stroke and access to acute ischemic stroke interventions, Neurology, 97, pp.S6-S16. doi:
10.1212/WNL.0000000000012781.
2. Han J, Mao W, et al(2020), Rate and determinants of recurrence at 1 year and 5 years after stroke in a low-income population in rural china, Front Neurol, 11 (2), pp.1-9. doi:
10.3389/fneur.2020.00002. eCollection 2020.
3. Kleindorfer DO, Towfighi A, et al(2021), 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association, Stroke, 52 (7), pp.e364-e467. doi: 10.1161/STR.0000000000000375.
4. Oza P, Rundell K, et al(2017), Recurrent Ischemic Stroke: Strategies for Prevention, Am Fam Physician, 96 (7), pp.436-440. http://www.aafp.org/afp/2007/0801/p389.html.
5. Khanevski AN, Bjerkreim AT, et al(2019), Recurrent ischemic stroke: incidence, predictors and impact on mortality, Acta Neurol Scand, 140 (1), pp.3-8. doi: 10.1111/ane.13093.
6. Kolmos M, Christoffersen L, Kruuse C(2021), Recurrent Ischemic Stroke – A Systematic Review and Meta-Analysis, Journal of Stroke and Cerebrovascular Diseases, 30 (8), pp.1-18. DOI: 10.1016/j.jstrokecerebrovasdis.2021.105935
7. Lê Thị Thu Trang(2017), Nghiên cứu đặc điểm lâm sàng, cận lâm sàng, một số yếu tố nguy cơ và kết quả điều trị ở bệnh nhân đột quỵ tái diễn tại Bệnh viện đa khoa Vĩnh Long, Luận án Chuyên khoa cấp II, Trường Đại học Y Dược Cần Thơ, Cần Thơ.
8. Powers WJ, Rabinstein AA, et al(2019), Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke, Stroke, 50, pp.e334-e418. doi.org/10.1161/STR.0000000000000211
9. Nguyen Thi Bich Huong, Nguyen Huy Thang(2020), Endovascular recanalization in early recurrent ischemic stroke: A treatment challenge, Case Rep Neurol, 12 (Suppl 1), pp.49–55. doi: 10.1159/000507185
10. Bouchal S, Lamrani YA, et al(2021), Repeated intravenous thrombolysis in early recurrent stroke secondary to carotid web: Case report", Radiol Case Rep, 16 (4), pp.843–846. doi: 10.1016/j.radcr.2021.01.026
11. Sarmiento RJC, Diestro JDB, et al(2019), Safety and efficacy of repeated thrombolysis with alteplase in early recurrent ischemic stroke: A systematic review, J Stroke Cerebrovasc Dis, 28 (10), pp.1-7. doi: 10.1016/j.jstrokecerebrovasdis.2019.07.006.
12. Kahles T, Mono ML, et al(2016), Repeated intravenous thrombolysis for early recurrent stroke:
Challenging the exclusion criterion, Stroke, 47 (8), pp.2133-5. DOI: 10.1161/STROKEAHA.116.013599.
13. Virani SS, Alonso A, et al(2020), Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association, Circulation, 141 (9), pp.e139-e596. DOI:
10.1161/CIR.0000000000000757.
14. Burke JP, Sander S, et al(2010), Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors, Curr Med Res Opin, 26 (5), pp.1023-30. DOI: 10.1185/03007991003670563.